|
2023
|
Invention
|
Pharmaceutically acceptable salt of heteroaryl derivative parp inhibitor and use thereof. The pre... |
|
|
Invention
|
Crystal form of heteroaryl derivative parp inhibitor and use thereof. The present invention relat... |
|
|
Invention
|
Nitrogen-containing heterocyclic derivative, and composition and pharmaceutical application there... |
|
|
Invention
|
Pyrazinone derivative and use thereof in medicine. The present invention relates to a compound as... |
|
|
Invention
|
Preparation method for 2-aminopyridine derivative. A preparation method for a 2-aminopyridine der... |
|
|
Invention
|
Pharmaceutical composition for injection comprising cyclic lactam compound and method for prepari... |
|
|
Invention
|
Dna polymerase θ inhibitor and use thereof. A nitrogen-containing heterocyclic compound represent... |
|
|
Invention
|
Dipeptidyl peptidase 1 inhibitor polymorph, preparation method and use therefor. Disclosed in the... |
|
|
Invention
|
Preparation method of nitrogen-containing heterocyclic compound. Disclosed is a preparation metho... |
|
|
Invention
|
Salt and crystal form of dipeptidyl peptidase inhibitor compound. Disclosed are a crystal of the ... |
|
|
Invention
|
Pyrazolopyridine derivative and application thereof in medicine. The present invention relates to... |
|
|
Invention
|
Mettl3 inhibitor and composition, and application of same in medicine. The present invention rela... |
|
|
Invention
|
Polymorph as thyroid hormone receptor agonists and use thereof. Disclosed in the present inventio... |
|
|
Invention
|
Preparation method of pyridazinone derivative, and intermediate thereof. Provided are a preparati... |
|
|
Invention
|
Azacyclic derivative and medical application thereof. The present invention relates to a compound... |
|
|
Invention
|
Tricyclic fused heterocyclic pde3/4 dual inhibitor and use thereof. Disclosed in the present inve... |
|
|
Invention
|
Nitrogen-containing heteroaromatic ring compound as well as composition and pharmaceutical use th... |
|
|
Invention
|
Compound for inhibiting or degrading hpk1 kinase and medical use thereof. The present invention r... |
|
2022
|
Invention
|
Compound for degradation of bcl-2 family proteins and medical application thereof. A compound of ... |
|
|
Invention
|
Benzo nitrogen-containing heteroaromatic ring derivative and use thereof in medicine. Provided ar... |
|
|
Invention
|
Heterocyclic derivative, and composition and pharmaceutical use thereof. Disclosed are a compound... |
|
|
Invention
|
Arylamino derivative estrogen receptor modulator and use thereof. The present invention relates t... |
|
|
Invention
|
Aak1 inhibitor and use thereof. A compound of formula (I) and a stereoisomer, deuterated compound... |
|
|
Invention
|
Small molecular cd73 antagonist and use thereof. Disclosed is a compound of formula (I), and a st... |
|
|
Invention
|
Phosphonyl derivative, and composition and pharmaceutical application thereof. Provided are the c... |
|
|
Invention
|
Fused-ring heterocycle derivative and medical application thereof. Provided are a compound repres... |
|
|
Invention
|
Use of peptide amide compound in preparation of drug for treating pruritus. Use of a compound rep... |
|
|
Invention
|
Salt and crystal form of ha inhibitor compound. Disclosed are a pharmaceutically acceptable salt ... |
|
|
Invention
|
Crystal form of anti-influenza virus compound, preparation method for crystal form, and use of cr... |
|
2021
|
Invention
|
Five-membered ring derivative and medical use thereof. A compound represented by general formula ... |
|
|
Invention
|
Ketohexokinase inhibitor and use thereof. Provided are a compound of formula (I), a stereoisomer,... |
|
|
Invention
|
Benzene ring derivative, and composition and pharmaceutical use thereof. Disclosed are a compound... |
|
|
Invention
|
Method for preparing btk degrading agent. The present invention relates to a method for preparing... |
|
|
Invention
|
Preparation method for btk degradation agent. A BTK Inhibitor compound and a preparation method f... |
|
|
Invention
|
Method for preparing btk degrading agent. A method for preparing a compound as represented by for... |
|
|
Invention
|
Deuterated derivative as atx inhibitor, and application thereof. Disclosed are a compound of form... |
|
|
Invention
|
Heterocyclic derivative and medical application thereof. A compound represented by general formul... |
|
|
Invention
|
Carbocyclic amide derivative and application thereof in medicine. Provided are a compound of gene... |
|
|
Invention
|
Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof. Provided is ... |
|
|
Invention
|
Method and system for determining population pharmacokinetic model of propofol and derivative the... |
|
|
Invention
|
Sustained-release pharmaceutical formulation of fused tricyclic ?-amino acid derivative and prepa... |
|
|
Invention
|
Sustained-release pharmaceutical formulation of fused tricyclic γ-amino acid derivative and prepa... |
|
|
Invention
|
Pb2 inhibitor, and preparation method therefor and use thereof. 112233 (I) |
|
|
Invention
|
Compound capable of inhibiting and degrading androgen receptors, and pharmaceutical compositions ... |
|
|
Invention
|
Compound having btk kinase degrading activity, and preparation method and pharmaceutical use ther... |
|
|
Invention
|
Fused-ring heterocycle derivative and medical use thereof. The present invention relates to a com... |
|
|
Invention
|
Pharmaceutical preparation and preparation method therefor. AAA receptor reinforcing agent is as ... |
|
|
Invention
|
Oral pharmaceutical composition. An oral pharmaceutical composition of a peptide amide compound (... |
|
2020
|
Invention
|
Nitrogen-containing heterocyclic autotaxin inhibitor, and composition containing same and use the... |
|
2019
|
Invention
|
Terpinoid derivatives and uses thereof.
Described herein are terpinoid derivatives as NRF2 inhib... |
